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Abstract
An important disadvantage of most indicators of health related quality of life used in public health
surveillance is their length. In this study the authors investigated the reliability and validity of a short
indicator of health related quality of life, the Dutch version of the four item ‘CDC Core Healthy Days
Measures’ (CDC HRQOL-4). The reliability was evaluated by calculating Cronbach’s alpha of the CDC
HRQOL-4. The concurrent validity was tested by comparing the CDC HRQOL-4 with three other indi-
cators of health related quality of life, the SF-36, the WHOQoL-BREF and the GHQ-12. The construct
validity was evaluated by assessing the ability of the CDC HRQOL-4 to discriminate between respondents
with and without a (non-mental) chronic condition, depression, a visit to the general practitioner and use of
prescription drugs. Randomly sampled respondents from the city of Utrecht were asked to fill in a ques-
tionnaire. 659 respondents (response rate 45%) completed the questionnaire. Participants represented the
adult, non-institutionalised population of the city of Utrecht, the Netherlands: 58% women; mean age
41 years; 15% of non-Dutch origin. The reliability of the CDC HRQOL-4 was good. Cronbach’s alpha of
three of the four CDC HRQOL-4-items was 0.77 which is good for internal consistent scales. The con-
current validity was good. The four items of the CDC HRQOL-4 showed higher correlations with their
corresponding domains of the other instrument than the other domains. Comparison of respondents with
or without a chronic condition, depression, visit to the GP and use of prescription drugs produced evidence
for an excellent construct validity of the CDC HRQOL-4.
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Introduction
Measuring ‘health related quality of life’ of pop-
ulations has been an integral part of the work of
public health epidemiologists for years [1]. Health
related quality of life (HRQoL) or self-reported
health status is not only a good predictor of
mortality and morbidity [2, 3], but also a good
outcome variable when studying trends in the
health status of populations [4, 5].
The SF-36 [6, 7] is a widely used indicator of
HRQoL in nation-wide and local health surveys.
Only recently its length is becoming a major
problem as other health indicators and risk factors
have been included in health surveys. A shorter
version of a HRQoL-measure also means far less
respondent burden [8]. Several shorter HRQoL-
measures have been developed during the past
years, some were abridged versions of the SF-36
(SF-12 [9]; SF-8 [10]; HSQ-12 [11]) others were
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newly developed (EQ-5D [12]; CDC Core Healthy
Days Measures, CDC HRQOL-4 [13]). In this
study the feasibility, reliability, concurrent and
construct validity of the CDC HRQOL-4 was
assessed in a general population health survey. The
CDC HRQOL-4 was chosen because of its short-
ness and apparent usefulness in the U.S.
Behavioural Risk Factor Surveillance System
(BRFSS) [14]
The SF-36 [15, 16], WHO quality of life assess-
ment instrument (WHOQoL-Bref) [17–19] and the
General Health Questionnaire (GHQ-12) [20–22]
were selected to evaluate the concurrent validity of
the CDC HRQOL-4.
The aims of this study were to assess:
(1) the reliability and feasibility of the CDC
HRQOL-4
(2) the concurrent and construct validity (extreme
groups) of the CDC HRQOL-4
This study was necessary because the CDC
HRQOL-4 has not been used before in the Neth-
erlands and cultural differences with the US made
it inevitable to assess its reliability, feasibility and
validity.
Methods
Study population and data collection
Postal questionnaires were sent to a random
sample of 1500 people with the Dutch nationality
aged 16–75 years, drawn from the municipal
population register of Utrecht (total population of
260,000), the Netherlands. The data collection
took place between November 2001 and January
2002. To reduce non-response a reminder was sent
to all the subjects 2 weeks after the mailing of the
questionnaires.
CDC health related quality of life-4
The US Centres for Disease Control and Preven-
tion (CDC) developed a set of survey measures to
assess a person’s sense of well-being through four
questions [8] These measures were included in the
BRFSS since 1993 [13] and the examination com-
ponent of the National Health and Nutricion
Examination Survey (NHANES) since 2000 (see
Box 1). Norwegian [23] and Swedish [24] versions
of the CDC HRQOL-4 were developed in the late
1990’s.
The Dutch version was translated according to
the international guidelines [25] using two inde-
pendent forward and backward translations.
Analysis
To evaluate the feasibility of the CDC HRQOL-4
we assessed the percentages of missing answers on
the four items, which were compared with those of
the three other used measures. Written comments
on the questionnaires were analysed to assess
whether the respondents encountered any difficul-
ties answering the four items of the CDC
HRQOL-4.
Cronbach’s alpha was used to evaluate the
internal consistency of three of the four CDC
HRQOL-4 items.
The concurrent validity was tested by assessing
whether the CDC HRQOL-4 items correlated
better with their assumed corresponding domains
of the SF-36 and WHOQoL BREF than the other
domains. Spearman’s rank correlation coefficients
were used because of the non-normal distribution
of the data.
The construct validity (extreme groups) was
tested by assessing the ability of the CDC
HRQOL-4 to discriminate between respondents
with and without a (non-mental) chronic condi-
tion, depression, a visit to the general practitioner
and use of prescription drugs.
Box 1. ‘Healthy Days’-questionnaire
1. Would you say that in general your health is
a. Excellent b. Very good c. Good d. Fair or e. Poor
2. Now thinking about your physical health, which includes
physical illness and injury, for how many days during the
past 30 days was your physical health not good?
...........days
3. Now thinking about your mental health, which includes
stress,
depression, and problems with emotions, for how many
days during the past 30 days was your mental health
not good?
.........days
4. During the past 30 days, for about how many days did poor
physical or mental health keep you from doing your usual
activities, such as self-care, work, or recreation?
............days
180
Mann–Whitney U-tests were used to assess the
differences between the subgroups.
Results
Response
Of the 1500 questionnaires distributed, 659 (45%)
were returned and were eligible for analysis.
Another 43 questionnaires were returned to sender
because the respondents had moved or were out of
the city/country for a longer period (mostly stu-
dents). More than half of the respondents were
female (58%) and the mean age was 41 years, 15%
was of non-Dutch ethnic origin. Nearly half of the
respondents (48%) had completed higher voca-
tional education or university. More than one
third of the respondents (35%) had a high income
(more than 2000 euro’s a month). Most respon-
dents were employed (58%) and 14% were stu-
dent.
Feasibility
All of the 4 CDC HRQOL-4 items had less than
5% missing answers, ranging from less than 1%
(self-perceived health) to 4%(mental unhealthy
days and days of activity limitation). In compari-
son with the other measures used in this study the
percentages of missing answers of the CDC
HRQOL-4 were reasonable. Analysis of the writ-
ten comments by the respondents showed no
difficulties in answering the four items of the CDC
HRQOL-4.
Internal consistency
Although the CDC HRQOL-4 consist of four
items the Cronbach’s alpha was calculated for the
three items relating to the number of days. The
first item (‘self-rated health’) was omitted because
of a different scaling. Cronbach’s alpha of the
three CDC HRQOL-4 items was 0.77 which is
greater than the 0.70 minimal standard recom-
mended for internal consistent scales [26].
Concurrent validity
The correlations between the CDC HRQOL-4 and
the SF-36-domains are shown in Table 1. Self-
rated health showed the highest association
()0,748) with the corresponding SF-36 domain.
The physically unhealthy days correlated better
with the 3 corresponding SF-36 physical-domains
than most of the other domains. The mentally
unhealthy days had higher correlations with the
two SF-36 mental-domains than all the other
domains.
The activity limitations days-measure had
higher correlations with the two ‘role-limitation’-
domains (physical and mental) and the social
functioning-domain than the other domains.
In Table 2 the correlations between the CDC
HRQOL-4, the WHOQoL–Bref-domains and the
GHQ-12 are shown. Self-rated health and the
Table 1. Concurrent validity of the CDC HRQOL-4 assessed by Spearman correlations between the CDC HRQOL-4 and SF-36-
domains and -summary scores





Physical Functioning )0.553 )0.426 )0.134 )0.354 )0.330
Role Physical )0.501 )0.524 )0.313 )0.578 )0.533
Bodily Pain )0.509 )0.497 )0.225 )0.421 )0.440
General Health )0.748 )0.469 )0.354 )0.452 )0.506
Vitality )0.490 )0.366 )0.585 )0.492 )0.608
Social Functioning )0.464 )0.473 )0.588 )0.651 )0.691
Role Emotional )0.311 )0.249 )0.655 )0.518 )0.561
Mental Health )0.398 )0.239 )0.713 )0.473 )0.581
Physical Component Scale )0.667 )0.587 )0.467 )0.637 )0.691
Mental Component Scale )0.587 )0.449 )0.687 )0.628 )0.736
All correlations are significant at the 0.01 level (2 tailed).
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physically unhealthy days-measure correlated
better with the WHOQoL–Bref physical health-
domain than the three other domains. The
mentally unhealthy days-measure had a higher
correlation with the WHOQoL–Bref mental
health-domain than the three other domains.
The GHQ-12 had a higher correlation with the
mentally unhealthy days-measure than the three
other CDC HRQOL-4-items.
Construct validity
Table 3 shows the ability of all the five CDC
HRQOL-4 to discriminate between respondents
without a chronic condition and those with one or
more conditions. Respondents suffering from
depression also reported higher numbers of
unhealthy (both physical and mental) days and
days with activity limitation than respondents
without a depression. As expected the difference
between respondent with or without a depression
was the biggest for the mentally unhealthy days
(15.5 vs. 2.5).
The same ability to discriminate was found for
respondents with or without a visit to a general
practitioner and the use of prescription drugs.
Discussion
In this study we examined the feasibility, reliability
and validity of the CDC HRQOL-4 in a commu-
nity survey setting. The feasibility of the CDC
HRQOL-4 was good, showing percentages of
missing values comparable with the other used
instruments and no difficulties in answering the
four items.
Table 3. Construct validity of the CDC HRQOL-4 assessed comparing groups with or without a chronic disease, depression,
GP-consultations and use of prescription drugs (percentages, means and their Standard Errors)








yes (n=225) 63% 8.5 (0.8) 6.4 (0.7) 5.9 (0.6) 11.5 (0.8)
no (n=405) 94% 2.2 (0.3) 3.5 (0.3) 2.4 (0.3) 5.3 (0.4)
Depression
yes (n=101) 59% 8.5 (1.1) 15.5 (1.1) 11.2 (1.1) 19.1 (1.1)
no (n=528) 87% 3.6 (0.3) 2.5 (0.3) 2.2 (0.3) 5.3 (0.4)
Visit to GP (2 months)
yes (n=266) 72% 7.8 (0.7) 6.7 (0.6) 6.5 (0.6) 11.8 (0.7)
no (n=356) 92% 1.9 (0.3) 2.8 (0.3) 1.6 (0.3) 4.1 (0.4)
Use of prescription drugs
yes (n=308) 71% 6.9 (0.6) 5.7 (0.5)* 5.6 (0.5) 10.3 (0.7)
no (n=321) 94% 2.0 (0.3) 3.2 (0.3) 1.8 (0.3) 4.8 (0.4)
All differences are significant at the 0.001 level (2 tailed) except * (0.01 level).
Table 2. Concurrent validity of the CDC HRQOL-4 assessed by Spearman correlations between the CDC HRQOL-4, WHOQoL–
Bref domains and GHQ-12
CDC HRQOL-4 fi Self-rated
Health





Physical health )0.609 )0.481 )0.463 )0.543 )0.610
Mental health )0.394 )0.216 )0.557 )0.406 )0.475
Social Relations )0.371 )0.220 )0.323 )0.263 )0.342
Environment )0.447 )0.313 )0.322 )0.377 )0.373
GHQ-12 )0.282 )0.289 )0.673 )0.541 )0.588
All correlations are significant at the 0.01 level (2 tailed).
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The internal consistency of three of the four
CDC HRQOL-4 items was good and comparable
with the other instruments used in this study.
The concurrent validity of the CDC HRQOL-4
was good. Comparison with the SF-36 showed
higher correlations for CDC HRQOL-4 with their
corresponding domain than with the other do-
mains. The same good concurrent validity was
found for the comparisons with the WHOQol-
BREF and the GHQ-12.
Comparison of respondents with or without a
chronic condition, depression, visit to the GP and
use of prescription drugs produced evidence for
an excellent construct validity of the CDC
HRQOL-4.
The findings of this study are in accordance with
previous validation studies of the CDC HRQOL-4
in the US. Andresen et al. [27] in a spinal cord
injured population and Newschaffer [28] in a
statewide sample found a good construct validity
of the US-version of the CDC HRQOL-4. Diwan
and Moriarty [29], Nanda and Andresen [30],
Andresen [31] and Moriarty and Zack [32] analy-
sed the CDC-HRQOL-4 in representative samples
and found a good internal consistency. They were
also able to identify known or suspected popula-
tion groups with unmet health-related needs.
Andresen et al. [33] found a moderate to excellent
retest reliability in a study using randomly sam-
pled respondents from the State of Missouri. The
only European validation study of the CDC
HRQOL-4 by Moum [23] also found a good
internal consistency. In the same study the
responsiveness of the CDC HRQOL-4 was as-
sessed and the follow-up survey of Norwegian
adults showed that response changes were indica-
tive of actual changes in respondent health status.
The main limitation of the study concerns the
‘internal’ design (only one sample, no retest-
reliability and no concurrent measurements from
external resources). Now that the first results of
the validation are promising further studies cov-
ering the ‘external’ aspect can be planned.
The overall conclusion of this study is that
the Dutch version of the CDC HRQOL-4 is a
promising instrument to replace longer health
status measures in public health surveillance in the
Netherlands. Further validation studies are needed
to assess the psychometric and other methodo-
logical aspects of the CDC HRQOL-4 that were
not covered by this study and previous validation
studies.
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